Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

Europe - EPA:BIM - FR0013280286 - Common Stock

114.7 EUR
+0.6 (+0.53%)
Last: 9/23/2025, 4:05:36 PM
Fundamental Rating

6

Taking everything into account, BIM scores 6 out of 10 in our fundamental rating. BIM was compared to 58 industry peers in the Health Care Equipment & Supplies industry. BIM has an excellent financial health rating, but there are some minor concerns on its profitability. BIM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BIM was profitable.
In the past year BIM had a positive cash flow from operations.
BIM had positive earnings in each of the past 5 years.
Each year in the past 5 years BIM had a positive operating cash flow.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

With a decent Return On Assets value of 7.04%, BIM is doing good in the industry, outperforming 79.31% of the companies in the same industry.
The Return On Equity of BIM (9.61%) is better than 67.24% of its industry peers.
BIM has a better Return On Invested Capital (8.55%) than 74.14% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BIM is in line with the industry average of 8.65%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.55%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BIM's Profit Margin of 9.17% is fine compared to the rest of the industry. BIM outperforms 67.24% of its industry peers.
In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
BIM's Operating Margin of 12.37% is in line compared to the rest of the industry. BIM outperforms 58.62% of its industry peers.
In the last couple of years the Operating Margin of BIM has grown nicely.
The Gross Margin of BIM (56.27%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
Compared to 5 years ago, BIM has less shares outstanding
Compared to 1 year ago, BIM has an improved debt to assets ratio.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 7.05 indicates that BIM is not in any danger for bankruptcy at the moment.
BIM's Altman-Z score of 7.05 is amongst the best of the industry. BIM outperforms 94.83% of its industry peers.
BIM has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
The Debt to FCF ratio of BIM (1.15) is better than 86.21% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that BIM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.09, BIM belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 7.05
ROIC/WACC1.08
WACC7.9%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.27 indicates that BIM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.27, BIM is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
BIM has a Quick Ratio of 1.30. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BIM (1.30) is better than 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

BIM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.23%.
Measured over the past years, BIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.91% on average per year.
Looking at the last year, BIM shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
The Revenue has been growing by 8.27% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.23%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

Based on estimates for the next years, BIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.69% on average per year.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 6.65% on average per year.
EPS Next Y18.23%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
EPS Next 5Y13.69%
Revenue Next Year6.26%
Revenue Next 2Y6.57%
Revenue Next 3Y6.74%
Revenue Next 5Y6.65%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.72, BIM can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BIM is valued a bit cheaper than 63.79% of the companies in the same industry.
BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
BIM is valuated rather expensively with a Price/Forward Earnings ratio of 22.38.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 60.34% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.87. BIM is around the same levels.
Industry RankSector Rank
PE 29.72
Fwd PE 22.38
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BIM is valued a bit cheaper than 67.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.9
EV/EBITDA 13.82
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
BIM's earnings are expected to grow with 14.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.63
PEG (5Y)2.72
EPS Next 2Y15.22%
EPS Next 3Y14.58%

4

5. Dividend

5.1 Amount

BIM has a yearly dividend return of 0.79%, which is pretty low.
BIM's Dividend Yield is a higher than the industry average which is at 2.14.
Compared to an average S&P500 Dividend Yield of 2.38, BIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.79%

5.2 History

On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BIM pays out 28.08% of its income as dividend. This is a sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.08%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (9/23/2025, 4:05:36 PM)

114.7

+0.6 (+0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-04 2025-09-04/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.58B
Analysts73.33
Price Target127.89 (11.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.79%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.08%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.31%
PT rev (3m)0.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 29.72
Fwd PE 22.38
P/S 3.29
P/FCF 30.9
P/OCF 17.23
P/B 3.45
P/tB 4.86
EV/EBITDA 13.82
EPS(TTM)3.86
EY3.37%
EPS(NY)5.12
Fwd EY4.47%
FCF(TTM)3.71
FCFY3.24%
OCF(TTM)6.66
OCFY5.8%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.63
PEG (5Y)2.72
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.69%
ROIC 8.55%
ROICexc 9.37%
ROICexgc 13.09%
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.66%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.33%
Cap/Sales 8.45%
Interest Coverage 250
Cash Conversion 79.99%
Profit Quality 116.27%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 7.05
F-Score8
WACC7.9%
ROIC/WACC1.08
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.23%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y18.23%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
EPS Next 5Y13.69%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year6.26%
Revenue Next 2Y6.57%
Revenue Next 3Y6.74%
Revenue Next 5Y6.65%
EBIT growth 1Y-1.89%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.41%
FCF growth 1Y133.85%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.85%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%